write about NTEP

Asking for Preferences
Reading File
Searching the Web

NTEP National Tuberculosis Elimination Programme India 2025 2026

Searching PubMed

National Tuberculosis Elimination Programme India NTEP

Reading Web Page

NTEP National Tuberculosis Elimination Programme India activities achievements

Finding Sources
Finding Sources
Searching the Web

NTEP India Nikshay Poshan Yojana BPaLM regimen TB Mukt Bharat 2025 2026 achievements

Here is a detailed account of India's National Tuberculosis Elimination Programme (NTEP):

National Tuberculosis Elimination Programme (NTEP)

Background and Evolution

India's fight against tuberculosis (TB) has a long institutional history. The Government of India (GOI) established a TB division under the Director General of Health Services (DGHS) in 1947, introduced bulk BCG vaccination in 1951, and launched the National Tuberculosis Control Programme (NTCP) in 1962. By 1997, recognizing the limitations of the NTCP, the government launched the Revised National Tuberculosis Control Programme (RNTCP), which introduced the internationally recommended DOTS (Directly Observed Treatment, Short-course) strategy.
On 1st January 2020, the RNTCP was officially renamed to the National Tuberculosis Elimination Programme (NTEP), signaling a shift from mere "control" to outright "elimination."

Vision and Target

India has committed to eliminate TB by 2025 - five years ahead of the WHO's global Sustainable Development Goal (SDG) target of 2030. The SDG targets (with 2015 as the baseline) are:
  • 80% reduction in TB incidence
  • 90% reduction in TB mortality
  • Zero TB patients or their households facing catastrophic costs due to TB
The foundation for this ambition was laid when Prime Minister Narendra Modi launched the "TB Free India" campaign at the Delhi End TB Summit on 13th March 2018.

National Strategic Plan (NSP) 2017-2025

NTEP operates under the National Strategic Plan (NSP) 2017-2025, which is driven by four strategic pillars known as "Detect - Treat - Prevent - Build" (DTPB):

1. DETECT

  • Active Case Finding (ACF): TB Mukt Bharat campaign for public awareness and early case finding
  • Community and institutional screening, especially in vulnerable populations
  • Engagement of private sector providers for case notification
  • Use of high-sensitivity molecular diagnostic tools (NAAT/CBNAAT/TrueNat)

2. TREAT

  • Prompt treatment with quality-assured first-line and second-line drug regimens
  • Decentralized, patient-centric care
  • Comprehensive care for drug-resistant TB (DR-TB), including the new BPaLM regimen (Bedaquiline, Pretomanid, Linezolid, Moxifloxacin) - a shorter, safer, and highly effective regimen for DR-TB patients
  • Addressing co-morbidities: malnutrition, diabetes, HIV, and substance abuse
  • Differentiated TB care model for early assessment and appropriate referral

3. PREVENT

  • Contact tracing among household contacts of TB patients
  • TB Preventive Treatment (TPT) for children, PLHIV (people living with HIV), and other high-risk groups
  • Airborne infection control measures in health facilities
  • Scale-up of TPT: approximately 15 lakh beneficiaries received TPT including shorter regimens

4. BUILD

  • Multi-sectoral response to address social determinants of TB (poverty, malnutrition, overcrowding)
  • Strengthening health system infrastructure
  • Capacity building of healthcare workers at all levels
  • Inter-ministerial convergence (Railways, ESI, Mines, Steel, Coal ministries)

Key Programmes and Schemes

Nikshay - Digital Backbone

Nikshay is the IT-enabled case notification and patient management system for TB in India. It serves as the central surveillance platform where all TB cases - from both public and private sectors - are registered and tracked. The Nikshay platform facilitates real-time monitoring of treatment adherence and outcomes.

Nikshay Poshan Yojana (NPY)

Launched in 2018, this scheme provides direct benefit transfer (DBT) of Rs. 500/month to every notified TB patient for nutritional support throughout their treatment. Given that TB patients require a high-protein diet to counter the side effects of treatment drugs, this financial aid directly addresses food insecurity - a major driver of treatment failure.

Pradhan Mantri TB Mukt Bharat Abhiyaan (PM-TBMBA)

Launched on 9th September 2022 by the President of India, this campaign is designed as a "Jan Andolan" (people's movement) to unite all sections of society. Its objectives are:
  • Provide additional nutritional, diagnostic, and vocational support to TB patients beyond what the government provides
  • Augment community involvement
  • Leverage Corporate Social Responsibility (CSR)

Ni-kshay Mitra Initiative

Under PM-TBMBA, individuals, NGOs, corporate houses, and elected representatives can adopt TB patients as Ni-kshay Mitras (TB Friends). They provide:
  • Food baskets (nutritional kits)
  • Psychosocial support
  • Vocational support for post-recovery rehabilitation
As of January 2026: More than 7 lakh Ni-kshay Mitras registered, over 22 lakh TB patients received nutritional support, and more than 49 lakh food baskets distributed.

100-Day TB Mukt Bharat Abhiyaan

Launched on 7th December 2024, this intensive campaign screened over 20 crore vulnerable people for TB and diagnosed more than 28 lakh TB patients within months.

Diagnostic Infrastructure

NTEP has massively expanded its laboratory network:
Facility20142023
Designated Microscopy Centers (DMCs)13,58324,573 (+80%)
Molecular diagnostic laboratories-6,496
Culture & Drug Susceptibility Testing (DST) labs-81
In 2023, the programme conducted approximately:
  • 1.89 crore sputum smear tests
  • 68.3 lakh NAAT (Nucleic Acid Amplification Tests)

Technology and Innovation

India's NTEP has adopted cutting-edge digital tools:
  • AI-powered cough screening: AI algorithms analyze cough sounds to detect TB
  • Radiology AI: AI reads chest X-rays for TB screening at scale
  • Predictive analytics: Identifies high-risk populations for targeted interventions
  • TB Mukt Bharat Mobile App: Patients can track Nikshay Poshan Kit delivery, report issues, and connect with Ni-kshay Mitras and health staff

Achievements (Key Metrics)

IndicatorProgress
TB incidence reduction (2015-2024)21% decline in new cases
TB mortality reduction (2015-2024)28% reduction
Treatment success rate (2023)87.6% (up from 84% in 2021)
TB case notifications (2023)25.5 lakh patients
TB-free Gram Panchayats (2024)46,118 certified
DR-TB treatment centres792 functional

Challenges

Despite significant progress, NTEP faces several hurdles:
  1. Drug-resistant TB: A 32% increase in DR-TB cases puts pressure on second-line drug supplies and specialized care facilities
  2. Private sector gap: One-third of notifications come from the private sector, but unnotified cases remain a significant challenge
  3. Social determinants: Poverty, malnutrition, and overcrowded living conditions continue to fuel transmission
  4. Health inequalities: Marginalized communities (tribal, migrant, urban slum populations) have lower access to services
  5. Catastrophic expenditure: Despite support schemes, many TB patients still face financial hardship
  6. Delays in DBT payments: Parliamentary records indicate delays in Nikshay Poshan Yojana payments reaching patients in several states

Administrative Structure

NTEP is implemented under the Ministry of Health and Family Welfare (MoHFW), with the Central TB Division (CTD) under the DGHS as the nodal body. It operates through a decentralized structure:
  • National level: CTD, Ministry of Health
  • State level: State TB Cells
  • District level: District TB Centres (DTCs)
  • Sub-district level: Tuberculosis Units (TUs) and Designated Microscopy Centres (DMCs)

Global Context

India carries the world's largest TB burden, accounting for approximately 26-27% of global TB cases. The trajectory of global TB elimination goals is therefore heavily dependent on India's success. The WHO's Global TB Report consistently tracks India's progress. The 21% reduction in incidence and 28% reduction in mortality from 2015-2024 are encouraging, but the pace needs to accelerate significantly to reach the 80%/90% targets by 2025 - a timeline that experts acknowledge as extremely challenging.

Sources: PIB India (March 2026) | DGHS MoHFW | Ni-kshay Mitra Guidance 2026 | Central TB Division, India TB Report 2024

Write about NACO

Searching the Web

NACO National AIDS Control Organisation India 2025 2026 NACP achievements

Searching PubMed

National AIDS Control Programme India HIV NACO

Finding Sources
Reading File
Reading Web Page

NACO NACP phases HIV programme India achievements ART targets

Reading File
Searching the Web

NACO India HIV statistics 2025 PLHIV ART coverage 95-95-95 progress

Reading File
Here is a detailed write-up on NACO:

National AIDS Control Organisation (NACO)

What is NACO?

The National AIDS Control Organisation (NACO) is a division of the Ministry of Health and Family Welfare (MoHFW), Government of India. It provides leadership, policy direction, and programmatic oversight for India's national HIV/AIDS and STI (Sexually Transmitted Infections) control response through 35 State AIDS Prevention and Control Societies (SACS).
NACO's vision is an India where every person living with HIV (PLHIV) receives quality care, free from stigma and discrimination. It focuses on awareness, prevention, early diagnosis, treatment access, and community empowerment.
Helpline: 1097 (Toll-Free, 24x7)

Historical Milestones

India's HIV response began the moment the first case was detected and has evolved steadily:
YearMilestone
1986First case of HIV detected in India; AIDS Task Force set up by ICMR; National AIDS Committee established
1987National AIDS Control Programme (NACP) launched
1990Medium Term Plan launched for 4 states and 4 metro cities
1992NACP Phase I launched; National AIDS Control Board constituted; NACO set up
1999NACP Phase II begins - focus on behaviour change, decentralization, NGO involvement; State AIDS Control Societies (SACS) established
2002National AIDS Control Policy adopted; National Blood Policy adopted
2004Antiretroviral Treatment (ART) initiated under the national programme
2006National Council on AIDS constituted under chairmanship of the Prime Minister; National Policy on Paediatric ART formulated
2007NACP Phase III launched (2007-2012)
2012NACP Phase IV launched (2012-2017)
2017National Strategic Plan for HIV/AIDS and STIs (2017-2024) formulated
2020Programme renamed to National AIDS and STD Control Programme
2021NACP Phase V launched (2021-2026)
(Source: Park's Textbook of Preventive and Social Medicine)

NACP Phases - Evolution of the Programme

NACP Phase I (1992-1999)

  • Aimed at slowing down the spread of HIV infection
  • Focused on surveillance, blood safety, and awareness generation
  • Built foundational infrastructure: NACO, SACS, blood banks

NACP Phase II (1999-2006)

  • Focus shifted to behaviour change communication (BCC)
  • Increased decentralization of programme implementation
  • Expanded NGO and civil society involvement
  • Launched targeted interventions for high-risk groups (sex workers, MSM, IDUs)

NACP Phase III (2007-2012)

  • Goal: Halt and reverse the HIV epidemic in India
  • Scaled up targeted interventions, ART services, PPTCT
  • Introduced Prevention of Parent to Child Transmission (PPTCT) as a major priority
  • Expanded to all districts; classified districts into categories A, B, C, D based on epidemiological criteria

NACP Phase IV (2012-2017)

  • Goal: Consolidate gains and accelerate reversal of the epidemic
  • Targeted a 50% reduction in new infections from the 2007 baseline
  • Provided comprehensive care and support to all PLHIV
  • Introduced HIV-TB collaboration and provider-initiated testing
  • Coverage of core high-risk groups (FSW, MSM, PWID) at 80%, 68%, 75% respectively by 2014-15

NACP Phase V (2021-2026)

NACP Phase V is a fully funded Central Scheme with a sanctioned budget of Rs. 15,471.94 crore. It integrates the UNAIDS Global AIDS Strategy (2021-2026) and WHO's Global Health Sector Strategies (2022-2030).
Five high-level goals of NACP Phase V:
  1. Reduce annual new HIV infections by 80% from the 2010 baseline by 2025-26
  2. Reduce AIDS-related mortalities by 80% from the 2010 baseline
  3. Eliminate vertical transmission (mother-to-child) of HIV and syphilis by 2025-26
  4. Achieve the 95-95-95 targets (see below)
  5. Eradicate HIV/AIDS-related stigma and discrimination

The 95-95-95 Targets

A central goal of NACP Phase V is achieving the UNAIDS 95-95-95 cascade:
TargetGoal
1st 9595% of all PLHIV know their HIV status
2nd 9595% of those who know their status are on ART
3rd 9595% of those on ART have suppressed viral load
India's progress (2020 data):
  • 78% of PLHIV aware of their status
  • 83% of diagnosed PLHIV on ART
  • 85% of those on ART with viral suppression
Progress is significant but gaps remain, particularly in reaching the first 95.

Organisational Structure

NACO operates through a decentralized structure:
  • National Level: NACO (Additional Secretary & Director General; Joint Secretary)
    • Divisions: Targeted Intervention & LWS, Basic Services (ICTC, PPTCT, HIV-TB), STI/RTI Management, Blood Safety, Lab Services, Care/Support/Treatment, IEC, Strategic Information, Admin & Procurement, Finance
  • State Level: 35 State AIDS Prevention and Control Societies (SACS)
  • District Level: District AIDS Prevention and Control Units (DAPCUs)
  • Facility Level: ART Centres, ICTCs, Link ART Centres, PPTCT facilities

Key Programme Components

1. Prevention - Targeted Interventions (TI)

Targeted interventions reach high-risk groups (HRGs) through outreach-based models, typically implemented by NGOs and community-based organisations:
  • Female Sex Workers (FSWs)
  • Men who have Sex with Men (MSM)
  • People who Inject Drugs (PWID)
  • Transgender persons
  • Bridge populations: Long-distance truckers (LDT), single male migrants (SMM)
Services include condom promotion, STI treatment, behaviour change counselling, and linkage to HIV testing and treatment.

2. HIV Testing - Integrated Counselling and Testing Centres (ICTC)

ICTCs are the gateway to HIV diagnosis across India. They operate at:
  • Fixed facility ICTCs - at hospitals and health facilities
  • Mobile ICTCs - for outreach to remote/unreached populations
Testing can be client-initiated (voluntary) or provider-initiated (PITC). Functions include early detection, counselling on transmission and prevention, and linking PLHIV to care and treatment.

3. Prevention of Parent-to-Child Transmission (PPTCT)

  • All pregnant women are tested for HIV at antenatal care
  • HIV-positive pregnant women are started on lifelong ART (Option B+)
  • Goal of NACP V: Eliminate vertical transmission (rate under 5%) by 2025-26
  • As of 2023-24, states like Maharashtra, Delhi, and Andhra Pradesh have achieved ARV coverage of 90-95%+ among HIV-positive mothers

4. Anti-Retroviral Treatment (ART)

  • Free ART is provided to all eligible PLHIV through a network of ART centres and Link ART Centres (LACs)
  • 14.94 lakh PLHIV were receiving ART as of 2020-21 (including 1.06 lakh in the private sector)
  • Viral load testing has expanded: 8.9 lakh tests in 2020-21 (up from 2.13 lakh in 2018-19)

5. Blood Safety

  • Mandatory HIV testing of all donated blood
  • Promotion of voluntary blood donation
  • Regulation and quality assurance of blood banks under the National Blood Policy (2002)

6. HIV-TB Collaboration

NACO and NTEP (formerly RNTCP) jointly implement the "Three I's for HIV/TB":
  • Intensified TB case finding among PLHIV
  • Isoniazid Preventive Therapy (IPT) for PLHIV without active TB
  • TB Infection Control in HIV care settings
Provider-initiated testing and counselling for TB patients has been scaled up, and 30 ART centres have capacity for CBNAAT-based TB detection.

7. STI/RTI Management

  • Free diagnosis and treatment of sexually transmitted infections (STIs) and reproductive tract infections (RTIs) at STI clinics nationwide
  • Syndromic case management approach
  • Integration with TI projects for high-risk groups

HIV Surveillance System

NACO runs a comprehensive HIV Sentinel Surveillance (HSS) system that monitors HIV trends across populations:
Surveillance TypeTarget Group
HIV Sentinel SurveillanceHRGs, bridge populations, pregnant women at ANC
HIV Sero-SurveillanceGeneral population samples
AIDS Case SurveillanceReported AIDS cases
STD SurveillanceSTI clinic attendees
Behavioural SurveillanceRisk behaviour trends
Integrated SurveillanceOverlap with TB and other diseases
Districts are classified into 4 categories (A, B, C, D) based on ANC prevalence and HRG data, and programme resources are allocated accordingly:
  • Category A: >1% ANC prevalence (high priority)
  • Category B: <1% ANC but >5% HRG prevalence
  • Category C & D: Lower prevalence states

Key Achievements

IndicatorAchievement
New HIV infections reduction (2010-2021)46% decline
AIDS-related mortality reduction (2010-2020)82% reduction (vs. global average of 47%)
Adult HIV prevalence (2020)0.22%
Estimated PLHIV (2020)~23.18 lakh
PLHIV on ART (2020-21)14.94 lakh
States with high HIV burdenAndhra Pradesh, Telangana, Karnataka, Maharashtra, Tamil Nadu
India's 82% reduction in AIDS-related deaths from 2010 to 2020 far surpasses the global average, making it one of the most remarkable achievements of the NACP.

Challenges

Despite major successes, NACO and NACP face ongoing challenges:
  1. First 95 gap: Only 78% of PLHIV know their status - a significant gap remains in HIV testing coverage
  2. Key population stigma: Stigma and discrimination continue to prevent HRGs from accessing services
  3. IDU/PWID interventions: Drug injection-driven HIV in the northeastern states remains difficult to address
  4. Private sector engagement: Many PLHIV seek care in the private sector and remain unnotified
  5. Paediatric HIV: Eliminating vertical transmission requires sustained ARV coverage, which remains below 75% in several northeastern states and UTs
  6. Funding dependency: A significant portion of the budget still relies on external donors (Global Fund, World Bank), raising sustainability concerns
  7. Viral suppression monitoring: Expanding viral load testing infrastructure beyond urban centres remains challenging

NACO and Global Alignment

NACO's strategy is aligned with:
  • UNAIDS Global AIDS Strategy (2021-2026) - "End Inequalities, End AIDS"
  • WHO Global Health Sector Strategies (2022-2030)
  • Sustainable Development Goal 3.3 - End AIDS as a public health threat by 2030
  • 95-95-95 UNAIDS targets by 2025

Sources: Park's Textbook of Preventive and Social Medicine (Ed. 26) | IMPRI India - NACP Phase V Analysis | PMC - India's HIV Programme | NACO official website | Nature Scientific Reports (2025) - Vertical Transmission Progress
This is a shared conversation. Sign in to Orris to start your own chat.